Academic
Publications
Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain

Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain,10.1007/s10495-011-0582-4,Apoptosis,Mar Orzáez,Anna Gortat,Mónica Sa

Characterization of dequalinium as a XIAP antagonist that targets the BIR2 domain  
BibTex | RIS | RefWorks Download
Inhibitor of apoptosis proteins (IAPs) regulate the activity of caspases in apoptosis. The human X chromosome-encoded IAP (XIAP) is one of the more potent members of the IAP family and it has been described as a central regulator of apoptosis. Thus, molecules that inhibit XIAP could offer therapeutic opportunities to treat unwanted apoptosis inhibition. In the present study we have applied the selective optimization of side activities (SOSA) approach to the discovery of XIAP inhibitors. In this sense, we have identified dequalinium hydrochloride (Dq) as an inhibitor of the XIAP/caspase-3 interaction both in vitro and in cellular assays.
Journal: Apoptosis , vol. 16, no. 5, pp. 460-467, 2011
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.